The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson’s disease

BACKGROUND: The PD COMM trial is a phase III multi-centre randomised controlled trial whose aim is to evaluate the effectiveness and cost-effectiveness of two approaches to speech and language therapy (SLT) compared with no SLT intervention (control) for people with Parkinson’s disease who have self...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Masterson-Algar, Patricia, Burton, Christopher R., Brady, Marian C., Nicoll, Avril, Clarke, Carl E., Rick, Caroline, Hughes, Max, Au, Pui, Smith, Christina H., Sackley, Catherine M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576370/
https://ncbi.nlm.nih.gov/pubmed/28851443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2130-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados